Jain Capsules & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 40 Year, 10 Days
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 3.45 Cr
About Jain Capsules & Chemicals
Jain Capsules & Chemicals Private Limited (JCCPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 1985 and has a history of 40 years. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.45 Cr.
Shailendra Jain and Sachin Jain serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1985PTC002741
-
Company No.
002741
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 1985
-
Date of AGM
30 Sep 2008
-
Date of Balance Sheet
31 Mar 2008
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Jain Capsules & Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailendra Jain
|
Director | 05-Feb-1985 | Current |
|
Sachin Jain
|
Director | 05-Feb-1985 | Current |
Financial Performance of Jain Capsules & Chemicals.
Enhance accessibility to Jain Capsules & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jain Capsules & Chemicals?
Unlock access to Jain Capsules & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹34.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.50 Cr
- Uco Bank : 0.68 Cr
- Central Bank Of India : 0.20 Cr
- Bank Of Maharashtra : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2005 | Axis Bank Limited | ₹2.50 Cr | Open |
| 20 Oct 2004 | Uco Bank | ₹6.80 M | Open |
| 01 Dec 1995 | Central Bank Of India | ₹1.50 M | Open |
| 01 Dec 1995 | Central Bank Of India | ₹0.50 M | Open |
| 06 Dec 1990 | Bank Of Maharashtra | ₹0.05 M | Open |
How Many Employees Work at Jain Capsules & Chemicals?
Unlock and access historical data on people associated with Jain Capsules & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jain Capsules & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jain Capsules & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
